Skip to main content
CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
1.790
+0.015 (0.85%)
Aug 14, 2025, 12:01 PM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Probody Therapeutics
101.21M
Log In
Log In
Log In
Log In
Upgrade
Probody Therapeutics Growth
90.38%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
101.21M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
90.38%
Log In
Log In
Log In
Log In
Upgrade